Economic Evaluation of Posaconazole Versus Fluconazole or Itraconazole in the Prevention of Invasive Fungal Infection in High-Risk Neutropenic Patients in Sweden

被引:0
|
作者
Johan Lundberg
Martin Höglund
Magnus Björkholm
Örjan Åkerborg
机构
[1] MSD Sweden (AB),Outcomes Research
[2] University Hospital,Division of Hematology, Department of Medical Science
[3] Karolinska University Hospital Solna,Department of Medicine
[4] Optum Insight,undefined
来源
关键词
Acute Myeloid Leukemia; Fluconazole; Itraconazole; Invasive Aspergillosis; Acute Myeloid Leukemia Patient;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:483 / 489
页数:6
相关论文
共 50 条
  • [41] A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies
    Morgenstern, GR
    Prentice, AG
    Prentice, HG
    Ropner, JE
    Schey, SA
    Warnock, DW
    BRITISH JOURNAL OF HAEMATOLOGY, 1999, 105 (04) : 901 - 911
  • [42] Cost-benefit Analysis of Posaconazole Versus Fluconazole or Itraconazole as a Primary Antifungal Prophylaxis in High-risk Hematologic Patients: A Propensity Score-matched Analysis
    Cho, Sung-Yeon
    Lee, Dong-Gun
    Choi, Jae-Ki
    Lee, Hyo-Jin
    Kim, Si-Hyun
    Park, Sun-Hee
    Choi, Su-Mi
    Choi, Jung-Hyun
    Yoo, Jin-Hong
    Kim, Yoo-Jin
    Kim, Hee-Je
    Min, Woo-Sung
    Back, Heejung
    Kang, Sukhyun
    Lee, Eui-Kyung
    CLINICAL THERAPEUTICS, 2015, 37 (09) : 2019 - 2027
  • [43] Fluconazole prophylaxis prevents invasive fungal infection in high-risk, very low birth weight infants
    Bertini, G
    Perugi, S
    Dani, C
    Filippi, L
    Pratesi, S
    Rubaltelli, FF
    JOURNAL OF PEDIATRICS, 2005, 147 (02): : 162 - 165
  • [44] Economic evaluation of posaconazole vs. standard azole prophylaxis in high risk neutropenic patients in the Netherlands
    Stam, Wiro B.
    O'Sullivan, Amy K.
    Rijnders, Bart
    Lugtenburg, Elly
    Span, Lambert F. R.
    Janssen, Jeroen J. W. M.
    Jansen, Jeroen P.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2008, 81 (06) : 467 - 474
  • [45] Economic evaluation of the prevention and management of systemic fungal infections in neutropenic patients
    Moeremans, Karen
    Annemans, Lieven
    EXPERT OPINION ON PHARMACOTHERAPY, 2006, 7 (14) : 1931 - 1943
  • [46] Cost-effectiveness of posaconazole versus fluconazole for prevention of invasive fungal infections in U.S. patients with graft-versus-host disease
    O'Sullivan, Amy K.
    Weinstein, Milton C.
    Pandya, Ankur
    Thompson, David
    Langston, Amelia A.
    Perfect, John R.
    Papadopoulos, George
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2012, 69 (02) : 149 - 156
  • [47] RANDOMIZED COMPARISON OF ORAL FLUCONAZOLE VERSUS ORAL POLYENES FOR THE PREVENTION OF FUNGAL INFECTION IN PATIENTS AT RISK OF NEUTROPENIA
    PHILPOTTHOWARD, JN
    WADE, JJ
    MUFTI, GJ
    BRAMMER, KW
    EHNINGER, G
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1993, 31 (06) : 973 - 984
  • [48] Intravenous-oral itraconazole versus oral posaconazole in preventing invasive fungal diseases for acute leukemia patients
    Liu, Li
    Pei, Xiaolei
    Ma, Runzhi
    He, Yi
    Zhang, Rongli
    Wei, Jialin
    Ma, Qiaoling
    Zhai, Weihua
    Pang, Aiming
    Jiang, Erlie
    Han, Mingzhe
    Yang, Donglin
    Feng, Sizhou
    BLOOD SCIENCE, 2023, 5 (02): : 106 - 110
  • [49] Posaconazole vs fluconazole or itraconazole for prevention of invasive fungal diseases in patients with acute myeloid leukemia or myelodysplastic syndrome: a cost-effectiveness analysis in an Asian teaching hospital
    Chan, Thomas S. Y.
    Marcella, Stephen W.
    Gill, Harinder
    Hwang, Yu-Yan
    Kwong, Yok-Lam
    JOURNAL OF MEDICAL ECONOMICS, 2016, 19 (01) : 77 - 83
  • [50] COST-EFFECTIVENESS OF POSACONAZOLE VERSUS FLUCONAZOLE IN THE PROPHYLAXIS OF INVASIVE FUNGAL INFECTIONS IN ACUTE LEUKEMIA PATIENTS IN COLOMBIA
    Sung, A.
    Monsanto, H.
    Ruiz, J.
    Beltran, C.
    Rojas, M.
    Cortes, M. F.
    Alvarez, C.
    Garzon, J.
    VALUE IN HEALTH, 2017, 20 (09) : A931 - A931